After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents

  • Cook-Deegan R
  • Niehaus A
N/ACitations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Genetic testing is becoming more common and more powerful by the day. The costs of the underlying DNA sequencing technology are plummeting, making it likely that tests based on it will become even more pervasive. The use of tests to determine DNA sequence to help make clinical decisions is here to stay. DNA sequencing is also finding new uses in forensics, determination of ancestry, understanding the history and genetic lineages of human populations and many other applications.

Cite

CITATION STYLE

APA

Cook-Deegan, R., & Niehaus, A. (2014). After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents. Current Genetic Medicine Reports, 2(4), 223–241. https://doi.org/10.1007/s40142-014-0055-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free